Watch for the company's response to the dissident slate, including any settlement or poison pill adoption. The annual meeting date has not yet been announced but will be a key catalyst. Monitor for additional proxy materials from both sides and any changes in insider trading patterns.
Price Chart
Executive Summary
Doug Bergeron (DGB Investment, Inc.), a 5.0% beneficial owner of Ethan Allen Interiors Inc. (NYSE: ETD), has escalated his proxy fight by filing definitive additional soliciting materials (DFAN14A) and posting campaign content on LinkedIn on October 7-8, 2026. This follows his August 5, 2026 nomination of six director candidates and the formation of an expanded group agreement on August 27, 2026, all aimed at replacing the board and CEO Farooq Kathwari, who has served for 38 years. Bergeron argues the company is materially undervalued and has the potential to triple shareholder value over three years, citing a two-decade revenue decline and poor digital/omnichannel execution.
Key Financial Metrics
Key Facts
- Activist Doug Bergeron, through DGB Investment, Inc., beneficially owns 5.0% of Ethan Allen common stock.
- Bergeron has nominated six director candidates for election at the 2026 Annual Meeting.
- The activist claims Ethan Allen has the potential to triple shareholder value over three years.
- Bergeron highlights a two-decade revenue decline and criticizes CEO Farooq Kathwari's 38-year tenure.
- The company reported $187.5 million in total cash and investments with no debt as of the latest fiscal 2026 earnings.
- Bergeron previously led a successful proxy campaign at Cantaloupe, Inc., resulting in an 89% total shareholder return and a sale for $848 million.
- This DFAN14A filing follows an August 5, 2026 SC 13D and an August 27, 2026 amended group agreement.
- The activist has launched a website (www.EthanAllenGrowth.com) for shareholder information.
Financial Impact
Activist claims potential to triple shareholder value over three years; company has $187.5M cash and no debt; activist stake is 5.0%.
Risk Factors
- Management may adopt a poison pill or other defensive measures, though these are often negotiated away.
- The activist's track record at Cantaloupe was successful, but past performance does not guarantee similar results at Ethan Allen.
- The company's entrenched board and long-tenured CEO may resist change, prolonging the proxy fight.
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DFAN14A Filing (Primary) | 0000921895-26-002766 |
| Document: 0000921895-26-002766-index-headers.html | 0000921895-26-002766 |
| Document: 0000921895-26-002766-index.html | 0000921895-26-002766 |
| Document: 0000921895-26-002766.txt | 0000921895-26-002766 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 27, 2026 today | Press Release | $20.49 | awaiting T+1 | — | $20.02 (−2.29%) |
Oct 26, 2026 today | DFAN14A | $20.08 | awaiting T+1 | — | $20.02 (−0.30%) |
Oct 22, 2026 4d ago | DFAN14A | $20.45 $20.08 | ▼ −1.81% | ▼ −2.52% | $20.02 (−2.10%) |
Oct 19, 2026 7d ago | DEFA14A | $20.16 $19.78 | ▼ −1.88% | ▼ −2.41% | $20.02 (−0.69%) |
Oct 19, 2026 8d ago | Press Release | $19.77 $20.16 | ▲ +1.97% | ▲ +1.64% | $20.02 (+1.26%) |
Oct 19, 2026 8d ago | Press Release | $19.77 | awaiting T+1 | — | $20.02 (+1.26%) |
Oct 15, 2026 11d ago | DEFA14A | $20.03 $19.77 | ▼ −1.30% | ▼ −1.72% | $20.02 (−0.05%) |
Oct 15, 2026 11d ago | Press Release | $20.03 $19.77 | ▼ −1.30% | ▼ −1.72% | $20.02 (−0.05%) |
Oct 15, 2026 11d ago | DEFA14A | $20.03 $19.77 | ▼ −1.30% | ▼ −1.72% | $20.02 (−0.05%) |
Oct 13, 2026 13d ago | DEFA14A | $20.06 $20.36 | ▲ +1.50% | ▲ +1.21% | $20.02 (−0.20%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers